Sun, Wei
Wu, Wei
Wang, Qifeng
Yao, Qian
Feng, Qin
Wang, Yue
Sun, Yu
Liu, Yunying
Lai, Qian
Zhang, Gu
Qi, Peng
Sun, Yifeng
Qian, Chenhui
Ren, Wanli
Luo, Zhengzhi
Chen, Jinying
Wang, Hongying
Xu, Qinghua https://orcid.org/0000-0002-6329-0119
Zhou, Xiaoyan
Sun, Wenyong
Lin, Dongmei
Funding for this research was provided by:
Innovation Program of Shanghai Science and Technology Committee grants (20Z11900300)
Innovation Group Project of Shanghai Municipal Health Commission grants (2019CXJQ03)
Shanghai Science and Technology Development Fund grants (19MC1911000)
Shanghai Municipal Key Clinical Specialty grants (shslczdzk01301)
the National Natural Science Foundation of China grants (81, 401, 963, 81, 972, 728)
Fudan University Shanghai Cancer Center grant (YJYQ201603)
Article History
Received: 21 January 2022
Accepted: 23 February 2022
First Online: 7 March 2022
Declarations
:
: In the study were obtained from the Clinical Research Ethics Committee of Beijing Cancer Hospital (BCH, Beijing, China), Fudan University Shanghai Cancer Center (FUSCC, Shanghai, China), and Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital (ZCH, Hangzhou, China)
: Not applicable.
: Author YF S, CH Q, WL R, ZZ L, JY C, HY W and QH X were employed by the company Canhelp Genomics Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.